Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Colorcon
AstraZeneca
Merck
Harvard Business School

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Litigation Details for Pfizer Inc. v. Dr. Reddy's Laboratories Ltd. (D. Del. 2015)

See Plans and Pricing

« Back to Dashboard

Pfizer Inc. v. Dr. Reddy's Laboratories Ltd. (D. Del. 2015)

Docket   Start Trial Date Filed 2015-11-18
Court District Court, D. Delaware Date Terminated 2016-02-08
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties DR. REDDY'S LABORATORIES INC.; DR. REDDY'S LABORATORIES LTD.; PFIZER INC.; UCB PHARMA GMBH
Patents 6,858,650; 7,384,980; 7,855,230; 7,985,772; 8,338,478
Attorneys Frank D. Rodriguez; Jack B. Blumenfeld; James P. Barabas; John C. Phillips , Jr.; Maryellen Noreika; Megan C. Haney
Firms Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Pfizer Inc. v. Dr. Reddy's Laboratories Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Pfizer Inc. v. Dr. Reddy's Laboratories Ltd. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-11-18 1 United States Patent Nos. 6,858,650 (“the ‘650 patent”), 7,384,980 (“the ‘980 patent”), 7,855,230 (“… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 6,858,650 21. Plaintiffs re-allege…(“the ‘230 patent”), 7,985,772 (“the ‘772 patent”), and 8,338,478 (“the ‘478 patent”), which cover, inter… 1. This is an action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 6. On February 22, 2005, the United States Patent and Trademark External link to document
2016-02-04 13 with, inter alia, infringement of U.S. Patent Nos. 6,858,650, 7,384,980, 7,855,230, 7,985,772 and 8,…2015 8 February 2016 1:15-cv-01067 830 Patent None District Court, D. Delaware External link to document
2016-02-08 14 with, inter alia, infringement of U.S. Patent Nos. 6,858,650, 7,384,980, 7,855,230, 7,985,772 and 8,338,478…2015 8 February 2016 1:15-cv-01067 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Dow
Merck
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.